Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.
Raeburn
D
D
Rhône-Poulenc Rorer Ltd., Dagenham Research Centre, Dagenham, Essex, England.
Souness
J E
JE
Tomkinson
A
A
Karlsson
J A
JA
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000037:antagonists & inhibitors* / Q000502:physiology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy*; D001665:Binding Sites; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D007527:Isoenzymes; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases